Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy

References

• Bao X, Wang W, Wang C, et al. (2014). A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Biomaterials 35:8450–66
   PubMed Web of Science ®Google Scholar
• Bernal GM, LaRiviere MJ, Mansour N, et al. (2014). Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 10:149–57
   PubMed Web of Science ®Google Scholar
• Bothun GD, Lelis A, Chen Y, et al. (2011). Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomedicine 7:797–805
   PubMed Web of Science ®Google Scholar
• Buie LW, Valgus JM. (2012). Current treatment options for the management of glioblastoma multiforme. Hematol Oncol Pharm 2:57–63
   Google Scholar
• Casagrande N, De Paoli M, Celegato M, et al. (2013). Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. Gynecol Oncol 131:744–52
   PubMed Web of Science ®Google Scholar
• Choi YH. (2014). Linoleic acid-induced growth inhibition of human gastric epithelial adenocarcinoma AGS cells is associated with down-regulation of prostaglandin E2 synthesis and telomerase activity. J Cancer Prev 19:31–8
   PubMedGoogle Scholar
• Das S, Ng WK, Tan RB. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51
   PubMed Web of Science ®Google Scholar
• Dong DW, Xiang B, Gao B, et al. (2013). pH-Responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials 34:4849–59
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang Y, Li D, et al. (2014). Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine 9:4107–16
   PubMed Web of Science ®Google Scholar
• Hejri A, Khosravi A, Gharanjig K, Hejazi M. (2013). Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem 141:117–23
   PubMed Web of Science ®Google Scholar
• Kaneshiro TL, Lu ZR. (2009). Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 30:5660–6
   PubMed Web of Science ®Google Scholar
• Kong F, Zhou F, Ge L, et al. (2012). Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine 7:1079–89
   PubMed Web of Science ®Google Scholar
• Leath CA III, Straughn JM Jr. (2013). Chemotherapy for advanced and recurrent cervical carcinoma: results fromcooperative group trials. Gynecol Oncol 129:251–7
   PubMed Web of Science ®Google Scholar
• Lee HG, Lee KS, Lee WH, Kim ST. (2014). Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri. Brain Tumor Res Treat 2:102–17
   PubMedGoogle Scholar
• Lee HS, Morrison ED, Frethem CD, et al. (2014). Cryogenic electron microscopy study of nanoemulsion formation from microemulsions. Langmuir 30:10826–33
   PubMed Web of Science ®Google Scholar
• Liu B, Han SM, Tang XY, et al. (2014). Cervical cancer gene therapy by gene loaded PEG-PLA nanomedicine. Asian Pac J Cancer Prev 15:4915–18
   PubMed Web of Science ®Google Scholar
• Liu C, Liu F, Feng L, et al. (2013). The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials 34:2547–64
   PubMed Web of Science ®Google Scholar
• Ma D, Lin QM, Zhang LM, et al. (2014). A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery. Biomaterials 35:4357–67
   PubMed Web of Science ®Google Scholar
• Messaoudi K, Saulnier P, Boesen K, et al. (2014). Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide. Int J Nanomedicine 9:1479–90
   PubMed Web of Science ®Google Scholar
• Morishima K, Sato T. (2014). Light scattering from hydrophobe-uptake spherical micelles near the critical micelle concentration. Langmuir 30:11513–19
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–55
   PubMed Web of Science ®Google Scholar
• Orza A, Soriţău O, Tomuleasa C, et al. (2013). Reversing chemoresistance of malignant gliomas stem cells using gold nanoparticles. Int J Nanomedicine 8:689–702
   PubMed Web of Science ®Google Scholar
• Podolska K, Stachurska A, Hajdukiewicz K, Małecki M. (2012). Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med 21:525–34
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Abouzeid AH, Torchilin VP. (2014). The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Eur J Pharm Biopharm 88:539–50
   PubMed Web of Science ®Google Scholar
• Saupe A, Wissing SA, Lenk A, et al. (2005). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) – structural investigations on two different carrier systems. Bio-Med Mater Eng 15:393–402
   PubMed Web of Science ®Google Scholar
• Shapiro WR, Shapiro JR. (1998). Biology and treatment of malignant glioma. Oncology 12:233–40
   PubMed Web of Science ®Google Scholar
• Shi F, Yang G, Ren J, et al. (2013). Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers. Int J Nanomedicine 8:2533–41
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, et al. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–66
   PubMed Web of Science ®Google Scholar
• Taratula O, Kuzmov A, Shah M, et al. (2013). Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 171:349–57
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. (2011). Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415:232–43
   PubMed Web of Science ®Google Scholar
• Yu W, Liu C, Ye J, et al. (2009). Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology 20:215102
   PubMed Web of Science ®Google Scholar
• Yu B, Tang C, Yin C. (2014). Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes. Biomaterials 35:6369–78
   PubMed Web of Science ®Google Scholar
• Yuan L, Liu C, Chen Y, et al. (2013). Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int J Nanomedicine 8:4339–50
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng M, Gong P, et al. (2013). Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterial 34:3431–8
   PubMed Web of Science ®Google Scholar